The Maritime and Commercial Court: CD Pharma has abused its dominant position by charging an excessive and unfair price for the drug Syntocinon

On 2 March 2020, the Maritime and Commercial Court has confirmed that it was illegal, when CD Pharma (a pharmaceutical distributor) abused its dominant position by increasing the price on Syntocinon from EUR 6 to a high level of EUR 127 corresponding to a price increase of 2,000 pct. The Competition Council first adopted a decision in the case in 2018.